Skip to content
Optellum
  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales
Menu Close
  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales

Author: Vaclav Potesil

This author has written 15 articles
Read more about the article New Appointments Strengthen Leadership Team

New Appointments Strengthen Leadership Team

  • Post published:February 13, 2020
  • Post category:News and PR/Team

Optellum has strengthened leadership team to support the commercialisation and clinical validation of its first product, and the development of product pipeline in the treatment of lung cancer and other…

Continue ReadingNew Appointments Strengthen Leadership Team
Read more about the article Optellum co-founder helps start the world’s first AI university.
Prof Sir Michael Brady at the Mohamed bin Zayed University of Artificial Intelligence

Optellum co-founder helps start the world’s first AI university.

  • Post published:October 17, 2019
  • Post category:News and PR

Optellum Chairman & co-founder, Prof. Sir Michael Brady FRS (center), is named the founding Board of Trustees member, and the interim President of the world's first AI University. Prof Sir…

Continue ReadingOptellum co-founder helps start the world’s first AI university.
Read more about the article Optellum at AI@Oxford Conference

Optellum at AI@Oxford Conference

  • Post published:September 18, 2019
  • Post category:Conference/News and PR

Optellum Founder and Chief Science & Technology Officer will share the lessons learned by Optellum in enabling early lung cancer diagnosis & treatment at the AI@Oxford congress. University of Oxford…

Continue ReadingOptellum at AI@Oxford Conference
Read more about the article Optellum Science at the World Conference on Lung Cancer
Barcelona

Optellum Science at the World Conference on Lung Cancer

  • Post published:September 7, 2019
  • Post category:Conference/News and PR

IASLC World Conference on Lung Cancer, the world's premier event for physicians and scientists advancing the fight against world's deadliest cancer, is taking place from September 7th till September 10…

Continue ReadingOptellum Science at the World Conference on Lung Cancer
Read more about the article Optellum selected for TMCx Accelerator at the world’s largest medical complex
Texas Medical Center

Optellum selected for TMCx Accelerator at the world’s largest medical complex

  • Post published:November 28, 2018
  • Post category:News and PR

The Optellum team is excited to be selected for the 2019 Digital Health Accelerator Cohort at TMCx, to be spend 4 months building our business with industry and clinical experts…

Continue ReadingOptellum selected for TMCx Accelerator at the world’s largest medical complex
Read more about the article Oxford secures £17.5 million to lead the world in imaging AI, in partnership with Optellum
Big Data Institute

Oxford secures £17.5 million to lead the world in imaging AI, in partnership with Optellum

  • Post published:November 6, 2018
  • Post category:Investment/News and PR/Partners

Optellum team and advisors took the lead role in preparing the winning bid, with Optellum Chairman,  Prof Sir Michael Brady FRS named the Executive Chairman of the NCIMI consortium led…

Continue ReadingOxford secures £17.5 million to lead the world in imaging AI, in partnership with Optellum
Read more about the article Optellum Science at the IASLC World Conference on Lung Cancer

Optellum Science at the IASLC World Conference on Lung Cancer

  • Post published:September 27, 2018
  • Post category:Conference/News and PR

This week Optellum has been highlighted in three presentations at the IASLC World Conference on Lung Cancer in Toronto, Canada. On Tuesday, Dr. Peter van Ooijen, from University Medical Centre…

Continue ReadingOptellum Science at the IASLC World Conference on Lung Cancer
Read more about the article Prof Sam Janes joins Optellum Medical Advisory Board
Prof Sam Janes MD FRCP

Prof Sam Janes joins Optellum Medical Advisory Board

  • Post published:June 22, 2018
  • Post category:Advisors/News and PR

Optellum welcomes an internationally renowned physician and scientist in early lung cancer diagnosis and treatment,  Dr. Sam Janes MD, to join its Medical Advisory Board. Prof. Janes works as a respiratory…

Continue ReadingProf Sam Janes joins Optellum Medical Advisory Board
Read more about the article Meet Optellum at the ATS 2018 Congress
Timor Kadir and Václav Potěšil at the Optellum booth

Meet Optellum at the ATS 2018 Congress

  • Post published:May 21, 2018
  • Post category:Event/News and PR

Join us at the American Thoracic Society 2018 Congress in San Diego,  North America's premier congress for pulmonary medicine, from May 20 till May 23. Meet us at Booth No…

Continue ReadingMeet Optellum at the ATS 2018 Congress
Read more about the article US National Lung Screening Trial PI visits Optellum

US National Lung Screening Trial PI visits Optellum

  • Post published:March 18, 2018
  • Post category:News and PR

Optellum is delighted to welcome Dr. Christine Berg, the co-Principal Investigator of the US National Lung Screening Trial (NLST), the biggest ever randomized clinical study,  to learn more about Optellum…

Continue ReadingUS National Lung Screening Trial PI visits Optellum
Read more about the article Leo Grady joins Optellum’s Scientific Advisory Board

Leo Grady joins Optellum’s Scientific Advisory Board

  • Post published:February 13, 2018
  • Post category:Advisors/News and PR

Optellum Scientific Advisory Board welcomes Leo Grady,  an internationally recognized expert in healthcare machine learning and building medical imaging Software-as-a-Service (SaaS) products. Leo Grady, Ph.D. (Senior Vice President of Engineering,…

Continue ReadingLeo Grady joins Optellum’s Scientific Advisory Board
Read more about the article BBC World News:  Optellum could save the National Health Service

BBC World News: Optellum could save the National Health Service

  • Post published:January 5, 2018
  • Post category:Media/News and PR

The government's healthcare tsar, Sir John Bell, has told BBC News that AI could "save the NHS".  Sir Bell, the Regius Professor of Medicine, has highlighted Optellum as a company…

Continue ReadingBBC World News: Optellum could save the National Health Service
  • 1
  • 2
  • Go to the next page

Optellum Ltd.

  • Oxford Centre for Innovation
    Oxford, OX1 1BY
    United Kingdom
  • info@optellum.comOpens in your application

Optellum Inc.

  • TMC Innovation Institute
    2450 Holcombe Blvd, Suite X
    Houston, TX 77021
    United States

Pages

  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales

Follow Us

  • Opens in a new tab
  • Opens in a new tab

Certifications

Copyright 2023 - Optellum Ltd | Privacy Policy
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}